From: miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma
 | DFS | OS | ||
---|---|---|---|---|
Variables | HR (95Â % CI) | p Value | HR (95Â % CI) | p Value |
Univariate analyses | ||||
Gender (male) | 0.715 (0.301-1.703) | 0.449 | 0.877 (0.311-2.472) | 0.804 |
Age (≥60y) | 0.721 (0.285-1.829) | 0.492 | 0.620 (0.220-1.747) | 0.366 |
HBsAg (positive) | 0.619 (0.276-1.389) | 0.245 | 0.728 (0.304-1.740) | 0.475 |
AFP (high) | 1.144 (0.629-2.078) | 0.659 | 1.026 (0.542-1.942) | 0.937 |
Vascular Invasion (positive) | 2.033 (0.998-4.141) | 0.051 | 1.545 (0.708-3.368) | 0.274 |
Tumer Size(≥5 cm) | 2.106 (1.161-3.818) | 0.014 | 2.303 (1.219-4.351) | 0.010 |
Edmondson Grade (III/IV) | 6.224 (3.183-12.168) | 0.000 | 3.546 (1.854-6.780) | 0.000 |
CD90High | 2.680 (1.398-5.135) | 0.003 | 3.072 (1.489-6.337) | 0.002 |
Multivariate analyses | ||||
Tumer Size(≥5 cm) | 1.642 (0.887-3.039) | 0.114 | 1.714 (0.898-3.271) | 0.102 |
Edmondson Grade (III/IV) | 5.426 (2.746-10.723) | 0.000 | 2.997 (1.555-5.776) | 0.001 |
CD90High | 1.926 (1.023-3.812) | 0.024 | 2.469 (1.179-5.169) | 0.016 |